People who may have participated in any clinical investigation having an investigational drug in 1 thirty day period before screening or in 5 50 %-lives with the investigational treatment whichever is for a longer period. , 2008). Tucidinostat has long been applied in medical trials to Enhance the therapeutic efficacy https://elenaw100itd2.wiki-racconti.com/user